Results Include Data from SVS TCAR Surveillance Project and ROADSTER-2 Study
Data from the Society for Vascular Surgery’s
- “Age and Outcomes After TransCarotid Artery Revascularization (TCAR), Transfemoral Carotid Artery Stenting (TF-CAS) and Carotid Endarterectomy (CEA)” (VESS14) will be presented by Dr.
Hanaa Dakour Aridiof Johns Hopkins University School of Medicineduring VESS Paper Session 1 on Wednesday, June 12at 10:45 a.m. ETin Maryland D.
- “Outcomes of TransCarotid Artery Revascularization (TCAR) versus Carotid Endarterectomy (CEA) in the TCAR Surveillance Project” (SSO1) will be presented by Dr.
Mahmoud Malasof the University of California, San DiegoSchool of Medicine on Thursday, June 13at 8:30 a.m. ETin Potomac A/B.
Final results of the ROADSTER-2 study will be featured in the late-breaking session on the final day of the meeting. “Analysis of the Early Outcomes in the ROADSTER-2 Clinical Trial of Transcarotid Artery Revascularization in Patients with Significant Carotid Artery Disease” will be presented by Dr.
About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System
TCAR (TransCarotid Artery Revascularization) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS) during the TCAR procedure. The ENROUTE Transcarotid NPS is a first in class device used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.
ENROUTE is a registered trademark of
Source: Silk Road Medical